Quick Takeaways
- Jane Pritchett Henderson has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $14,417,532.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Jane Pritchett Henderson
- Location
- Waltham, MA
- Summary
- The estimated net worth of Jane Pritchett Henderson is at least $14,417,532 dollars as of 04 May 2026. Jane Pritchett Henderson is the Chief Financial Officer of Apogee Therapeutics, Inc. and owns shares of Apogee Therapeutics, Inc. (APGE) stock worth about $14.42M.
- Signature
- /s/ Matthew Batters, as attorney-in-fact for Jane Pritchett Henderson
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jane Pritchett Henderson and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Apogee Therapeutics, Inc. ($14,417,532).
- Past-year value change for that position: -$2,092,807.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jane Pritchett Henderson
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| APGE | Apogee Therapeutics, Inc. | Chief Financial Officer | $14,417,532 | -$2,092,807 | -13% | 01 May 2026 |
| AKRO | Akero Therapeutics, Inc. | Director | $0 | -$142,371 | -100% | 09 Dec 2025 |
| IVVD | Adagio Therapeutics, Inc. | Chief Financial Officer | 30 Jan 2022 | |||
| CRGX | CARGO Therapeutics, Inc. | Director | 19 Aug 2025 | |||
| ISEE | IVERIC bio, Inc. | Director | 11 Jul 2023 | |||
| CARM | Sesen Bio, Inc. | Director | 03 May 2021 |
Insider Transactions Reported by Jane Pritchett Henderson:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.